Literature DB >> 17652769

The initial surface composition and topography modulate sphingomyelinase-driven sphingomyelin to ceramide conversion in lipid monolayers.

Luisina De Tullio1, Bruno Maggio, Steffen Hartel, Jorge Jara, Maria Laura Fanani.   

Abstract

Changes of the initial composition and topography of mixed monolayers of Sphingomyelin and Ceramide modulate the degradation of Sphingomyelin by Bacillus cereus Sphingomyelinase. The presence of initial lateral phase boundary due to coexisting condensed and expanded phase domains favors the precatalytic steps of the reaction. The amount and quality of the domain lateral interface, defined by the type of boundary undulation, appears as a modulatory supramolecular code which regulates the catalytic efficiency of the enzyme. The long range domain lattice structuring is determined by the Sphingomyelinase activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652769     DOI: 10.1007/s12013-007-0001-1

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  3 in total

1.  Lipid raft composition modulates sphingomyelinase activity and ceramide-induced membrane physical alterations.

Authors:  Liana C Silva; Anthony H Futerman; Manuel Prieto
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

2.  Sphingomyelinase-induced domain shape relaxation driven by out-of-equilibrium changes of composition.

Authors:  Maria Laura Fanani; Luisina De Tullio; Steffen Hartel; Jorge Jara; Bruno Maggio
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

3.  Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease.

Authors:  Marta Pera; Delfina Larrea; Cristina Guardia-Laguarta; Jorge Montesinos; Kevin R Velasco; Rishi R Agrawal; Yimeng Xu; Robin B Chan; Gilbert Di Paolo; Mark F Mehler; Geoffrey S Perumal; Frank P Macaluso; Zachary Z Freyberg; Rebeca Acin-Perez; Jose Antonio Enriquez; Eric A Schon; Estela Area-Gomez
Journal:  EMBO J       Date:  2017-10-10       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.